MedTrace Logo

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

NCT04344002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 886

Last updated 2022-06-27

No results posted yet for this study

Summary

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members.

The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

Conditions

Sponsors & Collaborators

  • Spanish Lung Cancer Group

    lead OTHER

Principal Investigators

  • Mariano MD Provencio, MD · Hospital Puerta de Hierro de Majadahonda de Madrid

  • Cristina MD Avendaño Solá, MD · Hospital Puerta de Hierro de Majadahonda de Madrid

  • María MD González-Cao, MD · Hospital Universitario Dexeus de Barcelona.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-21
Primary Completion
2021-10-06
Completion
2021-10-06

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04344002 on ClinicalTrials.gov